Influence of dialysis techniques and alternate vitamin supplementation on homocysteine levels in patients with known MTHFR genotypes
- PMID: 24652221
- DOI: 10.1007/s10157-014-0961-6
Influence of dialysis techniques and alternate vitamin supplementation on homocysteine levels in patients with known MTHFR genotypes
Abstract
Background: Treatment with folic acid and vitamin B12 appears capable of reducing total plasma homocysteine levels (tHcy), but it is unknown whether vitamin B12 alone reduces tHcy values. In this study we investigate the effects of alternate vitamins supplementation on homocysteine levels in patients treated by diffusive and convective dialysis techniques.
Methods: 74 patients were randomized blindly into two groups of 37 subjects each. The first group was treated initially with vitamin B12 for 2 months and with folic acid for the following 2 months. The second group was treated initially with folic acid. A wash out period of 2 months followed the treatment in both groups.
Results: Total homocysteine levels decreased in both groups following the alternate vitamins therapy and dialysis, without significant difference between diffusive and convective techniques. Surprisingly, after the wash-out period, tHcy increased remarkably, regardless of the dialysis procedure used. At the end of the study, folate levels showed a higher reduction with haemodialysis compared to haemodiafiltration. In contrast, vitamin B12 levels showed a significant increase using diffusive haemodialysis, confirming a decisive role of membrane performance.
Conclusions: In conclusion we show for the first time that, even if total homocysteine levels decreased in both dialysis procedures, the convective techniques demonstrate a superior capacity on the reduction of tHcy levels compared to the diffusive method. Moreover, the lower depletion of vitamin B12 by diffusive techniques could determine a higher reduction of folate levels, demonstrating the decisive role of the membrane performance in the treatment of this patients.
Similar articles
-
The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.J Nephrol. 2016 Oct;29(5):691-8. doi: 10.1007/s40620-015-0235-8. Epub 2015 Nov 11. J Nephrol. 2016. PMID: 26559681 Clinical Trial.
-
Effects of folic acid before and after vitamin B12 on plasma homocysteine concentrations in hemodialysis patients with known MTHFR genotypes.Clin Chem. 2006 Jan;52(1):145-8. doi: 10.1373/clinchem.2005.056119. Clin Chem. 2006. PMID: 16391331 Clinical Trial.
-
Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.Nephrol Dial Transplant. 2002 Mar;17(3):455-61. doi: 10.1093/ndt/17.3.455. Nephrol Dial Transplant. 2002. PMID: 11865092
-
Homocysteine, B-vitamins and CVD.Proc Nutr Soc. 2008 May;67(2):232-7. doi: 10.1017/S0029665108007076. Proc Nutr Soc. 2008. PMID: 18412997 Review.
-
Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease.Expert Opin Investig Drugs. 2000 Nov;9(11):2637-51. doi: 10.1517/13543784.9.11.2637. Expert Opin Investig Drugs. 2000. PMID: 11060826 Review.
Cited by
-
The Impact of Chronic Kidney Disease on Nutritional Status and Its Possible Relation with Oral Diseases.Nutrients. 2022 May 10;14(10):2002. doi: 10.3390/nu14102002. Nutrients. 2022. PMID: 35631140 Free PMC article. Review.
-
Impact of Physical Activity and Natural Bioactive Compounds on Endothelial Dysfunction in Chronic Kidney Disease.Life (Basel). 2021 Aug 17;11(8):841. doi: 10.3390/life11080841. Life (Basel). 2021. PMID: 34440585 Free PMC article. Review.
-
Interventions for lowering plasma homocysteine levels in dialysis patients.Cochrane Database Syst Rev. 2016 May 31;2016(5):CD004683. doi: 10.1002/14651858.CD004683.pub4. Cochrane Database Syst Rev. 2016. PMID: 27243372 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical